Staccato Cherry U.S. Plant Patent Invalidated By Brian D. Keppler, Ph.D. On December 30, 2022, a federal judge in the Eastern District of Washington granted a motion for summary judgment seeking to invalidate U.S. Plant Patent No. 20,551, covering a variety of cherry known as Staccato. Staccato is a sweet cherry variety developed by Agriculture and Agri-Food Canada. The Canadian government, the owner and assignee of […] Continue Reading →
Supreme Court Rules: Sale of Invention can Prevent Patenting Following passage of the America Invents Act, questions arose as to whether a secret sale by the inventor more than one year before patenting was prior art under section 102(a)(1) that would prohibit patenting of the invention. The language of the statute provides an invention cannot be patented if “in public use, on sale, or […] Continue Reading →
Protecting Your Nanotechnology Inventions – Part 4: Don’t Forget About Trade Secret Protection By Jonathan L. Kennedy When you have a new invention, the right question to ask at the outset is whether you want to consider patenting it. This is important because many common activities in research and commercialization can create a bar to patent protection or at least start a one-year clock by which a patent must be filed. Some […] Continue Reading →
Is your Confidential Sale Prior Art Against You? The Supreme Court has Decided to Weigh In. You have a new idea and have found an interested buyer. If you sell your product or process to the buyer prior to filing a patent application, have you created your own prior art? If it is prior art, it would bar a later filed patent under 35 USC §102. Prior to the change in […] Continue Reading →
Supplier’s Agreement to Manufacture May Trigger On-Sale Bar In an Opinion on August 14, 2013 (Hamilton Beach Brands, Inc. v. Sunbeam Products, Inc.), the Federal Circuit ruled that the on-sale bar was triggered when a purchase order for slow cookers by patentee Hamilton Beach was confirmed by its supplier. The Court stated that Hamilton Beach’s transaction with its supplier was an offer for […] Continue Reading →
Ninth Circuit: Sufficient evidence of fraud to defeat summary judgment on Walker Process claim In a recent decision, the Ninth Circuit addressed the antitrust implications of so-called "reverse payments" between brand name and generic pharmaceutical companies. A health care provider brought suit against the two companies, alleging their agreement to delay the introduction of a generic pharmaceutical (which involved payment to the generic manufacturer of $4.5 million per month) […] Continue Reading →
Today’s lesson for litigators: make sure you present all your arguments to the district court In a decision Tuesday, the Federal Circuit affirmed a district court's holding that two patents were invalid under the on-sale bar of 35 U.S.C. § 102(b). The inventor filed a declaration during prosecution that the invention was reduced to practice before the critical date of the patents, and thereafter sold the claimed method, also before […] Continue Reading →
On-sale bar cannot be avoided by experimentation conducted by patentee’s customer In a decision Thursday, the Federal Circuit provided additional guidance on the on-sale bar of § 102(b). In the case, the patentee developed a series of prototypes that were then sold to its customer, who then experimented with the prototypes and requested modifications to the prototypes. The prototypes were also accompanied by offers to sell […] Continue Reading →
Federal Circuit addresses claim construction, on-sale and public use bars, and DJ jurisdiction In a decision Friday, the Federal Circuit vacated in part a district court's claim construction of a several terms as well as its decision to find no infringement of patents owned by Honeywell. The court did, however, affirm the district court's retention of jurisdiction over the several withdrawn claims and the decision that Honeywell's pre-critical […] Continue Reading →